Summary & Overview
CPT 86256: Fluorescent Immunoassay for Antibody Titer to Noninfectious Agent
CPT code 86256 denotes a laboratory fluorescent immunoassay used to titer antibodies to a noninfectious agent in a patient’s blood, typically serum. This code represents a specialized serologic test that supports diagnostic and monitoring decisions in clinical immunology and related specialties. Nationally, such assays are important for confirming immune responses to vaccines, evaluating alloimmune or autoimmune markers, and guiding clinical management where quantitative antibody measurement is required.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage patterns, coding guidance, and common billing modifiers that may apply to laboratory services involving CPT code 86256.
Readers will learn the clinical context and intended use of the test, typical sites of service, and what to expect in payer interactions. The report summarizes benchmark considerations and administrative details relevant to billing and reimbursement workflows. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 86256 describes a fluorescent immunoassay to titer antibodies to a noninfectious agent in a patient’s blood, typically performed on serum. The procedure measures the amount of specific antibody using fluorescent labeling to quantify the immune response to a noninfectious target.
Service type: Laboratory diagnostic test (serologic antibody titer by fluorescent immunoassay)
Typical site of service: Clinical laboratory or hospital laboratory
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 45-year-old patient presents to an outpatient laboratory after referral from an immunology clinic for quantitative antibody titering to a noninfectious antigen following immunization and to assess humoral immunity. The clinician orders a fluorescent immunoassay to measure specific antibody concentration in serum. The patient has blood drawn in the phlebotomy area of an ambulatory laboratory; the specimen is labeled, processed, and sent to the clinical laboratory. A medical technologist performs the fluorescent immunoassay (reported with 86256) to determine the antibody titer. Results are reported to the ordering provider, who uses the quantitative value to guide clinical decisions such as booster vaccination, immunodeficiency evaluation, or monitoring of therapeutic response.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation/reporting component separate from the technical component. |
TC | Technical component | Use when billing only the technical component (laboratory processing and equipment) of the test. |